Hari Eswaran
Concepts (241)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetoencephalography | 30 | 2024 | 117 | 8.830 |
Why?
| Magnetocardiography | 13 | 2025 | 51 | 6.560 |
Why?
| Fetus | 25 | 2025 | 218 | 5.720 |
Why?
| Heart Rate, Fetal | 12 | 2025 | 73 | 3.890 |
Why?
| Pregnancy | 52 | 2025 | 2609 | 3.710 |
Why?
| Telemedicine | 14 | 2024 | 467 | 3.410 |
Why?
| Brain | 20 | 2020 | 1311 | 3.260 |
Why?
| Fetal Heart | 6 | 2025 | 29 | 2.330 |
Why?
| Fetal Development | 9 | 2023 | 59 | 2.140 |
Why?
| Uterine Contraction | 6 | 2016 | 37 | 2.100 |
Why?
| Pelvic Floor | 3 | 2024 | 51 | 2.020 |
Why?
| Female | 70 | 2025 | 26829 | 1.870 |
Why?
| Fetal Monitoring | 6 | 2025 | 42 | 1.850 |
Why?
| Gestational Age | 22 | 2025 | 422 | 1.800 |
Why?
| Prenatal Diagnosis | 6 | 2021 | 108 | 1.740 |
Why?
| Electromyography | 4 | 2018 | 131 | 1.720 |
Why?
| Pregnant Women | 3 | 2023 | 76 | 1.660 |
Why?
| Evoked Potentials, Auditory | 12 | 2020 | 101 | 1.550 |
Why?
| Electroencephalography | 6 | 2020 | 303 | 1.540 |
Why?
| Humans | 79 | 2025 | 50201 | 1.450 |
Why?
| Pregnancy Complications | 3 | 2023 | 381 | 1.220 |
Why?
| Myography | 4 | 2024 | 15 | 1.210 |
Why?
| Adult | 27 | 2025 | 13486 | 1.160 |
Why?
| Feasibility Studies | 4 | 2024 | 383 | 1.160 |
Why?
| Evoked Potentials, Visual | 8 | 2020 | 37 | 1.140 |
Why?
| Infant, Newborn | 19 | 2023 | 2770 | 1.140 |
Why?
| Buprenorphine | 2 | 2019 | 144 | 1.100 |
Why?
| Algorithms | 6 | 2020 | 615 | 1.070 |
Why?
| Brain Mapping | 6 | 2013 | 227 | 1.010 |
Why?
| Aftercare | 2 | 2022 | 74 | 0.990 |
Why?
| Obstetric Labor, Premature | 4 | 2016 | 38 | 0.980 |
Why?
| Pregnancy Trimester, Third | 6 | 2023 | 63 | 0.980 |
Why?
| Signal Processing, Computer-Assisted | 4 | 2018 | 69 | 0.980 |
Why?
| Leg Ulcer | 1 | 2024 | 1 | 0.970 |
Why?
| Premature Birth | 3 | 2021 | 146 | 0.920 |
Why?
| Brain Waves | 2 | 2016 | 18 | 0.910 |
Why?
| Brain-Derived Neurotrophic Factor | 1 | 2024 | 33 | 0.890 |
Why?
| Fetal Blood | 1 | 2024 | 71 | 0.880 |
Why?
| Muscle Strength | 1 | 2024 | 128 | 0.870 |
Why?
| Diabetes, Gestational | 1 | 2023 | 52 | 0.820 |
Why?
| Interleukin-6 | 1 | 2024 | 266 | 0.820 |
Why?
| Evoked Potentials | 2 | 2021 | 72 | 0.810 |
Why?
| Prenatal Care | 1 | 2023 | 108 | 0.780 |
Why?
| Auditory Cortex | 2 | 2020 | 22 | 0.780 |
Why?
| Hydroxyprogesterones | 1 | 2021 | 7 | 0.750 |
Why?
| Delivery of Health Care | 3 | 2024 | 308 | 0.750 |
Why?
| Hypertension | 2 | 2023 | 541 | 0.740 |
Why?
| Opioid-Related Disorders | 3 | 2024 | 387 | 0.730 |
Why?
| Heart Rate | 3 | 2023 | 301 | 0.720 |
Why?
| Pre-Eclampsia | 2 | 2020 | 54 | 0.710 |
Why?
| Breast Feeding | 1 | 2022 | 189 | 0.710 |
Why?
| Pregnancy in Diabetics | 1 | 2020 | 28 | 0.690 |
Why?
| Diabetes Mellitus | 2 | 2021 | 281 | 0.680 |
Why?
| Young Adult | 9 | 2024 | 4052 | 0.670 |
Why?
| Pregnancy Outcome | 4 | 2023 | 237 | 0.670 |
Why?
| Obstetrics | 2 | 2020 | 88 | 0.620 |
Why?
| Narcotic Antagonists | 1 | 2019 | 135 | 0.610 |
Why?
| Opiate Substitution Treatment | 1 | 2019 | 94 | 0.600 |
Why?
| Heart Defects, Congenital | 1 | 2024 | 590 | 0.600 |
Why?
| Pilot Projects | 4 | 2023 | 703 | 0.600 |
Why?
| Cardiotocography | 2 | 2011 | 8 | 0.590 |
Why?
| Labor Onset | 2 | 2010 | 4 | 0.580 |
Why?
| United States | 11 | 2024 | 4898 | 0.570 |
Why?
| Magnetics | 4 | 2009 | 39 | 0.570 |
Why?
| Monitoring, Ambulatory | 1 | 2017 | 7 | 0.570 |
Why?
| Health Services Accessibility | 4 | 2023 | 420 | 0.570 |
Why?
| Medicare | 3 | 2023 | 245 | 0.570 |
Why?
| Postpartum Period | 2 | 2020 | 110 | 0.570 |
Why?
| Action Potentials | 3 | 2018 | 132 | 0.560 |
Why?
| Fetal Growth Retardation | 3 | 2013 | 42 | 0.560 |
Why?
| Sleep | 3 | 2013 | 179 | 0.550 |
Why?
| Magnesium Sulfate | 1 | 2016 | 13 | 0.550 |
Why?
| Quality of Life | 1 | 2022 | 843 | 0.530 |
Why?
| Colposcopy | 1 | 2016 | 18 | 0.530 |
Why?
| Pregnancy, High-Risk | 5 | 2017 | 60 | 0.520 |
Why?
| Disposable Equipment | 1 | 2016 | 5 | 0.520 |
Why?
| Uterine Monitoring | 1 | 2016 | 6 | 0.520 |
Why?
| Appointments and Schedules | 1 | 2015 | 25 | 0.500 |
Why?
| Neuroprotective Agents | 1 | 2016 | 100 | 0.500 |
Why?
| Abdomen | 1 | 2015 | 77 | 0.490 |
Why?
| Anticonvulsants | 1 | 2016 | 125 | 0.490 |
Why?
| Gynecology | 1 | 2015 | 49 | 0.480 |
Why?
| Ambulatory Care Facilities | 1 | 2015 | 121 | 0.480 |
Why?
| Muscle, Skeletal | 2 | 2018 | 781 | 0.460 |
Why?
| Rural Health Services | 1 | 2016 | 168 | 0.450 |
Why?
| Monitoring, Physiologic | 3 | 2023 | 127 | 0.450 |
Why?
| Diagnosis, Computer-Assisted | 2 | 2011 | 47 | 0.440 |
Why?
| Uterine Cervical Neoplasms | 1 | 2016 | 277 | 0.430 |
Why?
| Male | 18 | 2024 | 25572 | 0.420 |
Why?
| Analgesics, Opioid | 1 | 2018 | 562 | 0.410 |
Why?
| Medicaid | 4 | 2023 | 256 | 0.410 |
Why?
| Prospective Studies | 5 | 2022 | 2396 | 0.400 |
Why?
| Uterus | 3 | 2015 | 91 | 0.390 |
Why?
| Magnetometry | 2 | 2025 | 5 | 0.390 |
Why?
| Arkansas | 7 | 2024 | 1988 | 0.380 |
Why?
| Muscle Contraction | 2 | 2024 | 111 | 0.370 |
Why?
| Acoustic Stimulation | 6 | 2021 | 97 | 0.370 |
Why?
| Fetal Organ Maturity | 1 | 2011 | 9 | 0.370 |
Why?
| Photic Stimulation | 4 | 2021 | 59 | 0.360 |
Why?
| Retrospective Studies | 7 | 2024 | 6190 | 0.350 |
Why?
| Pandemics | 6 | 2024 | 567 | 0.340 |
Why?
| Myometrium | 1 | 2010 | 14 | 0.340 |
Why?
| Patient Discharge | 2 | 2022 | 322 | 0.340 |
Why?
| Reproducibility of Results | 6 | 2019 | 1195 | 0.340 |
Why?
| Cost-Benefit Analysis | 2 | 2023 | 270 | 0.320 |
Why?
| Labor, Obstetric | 1 | 2009 | 44 | 0.320 |
Why?
| Cohort Studies | 4 | 2020 | 1414 | 0.310 |
Why?
| Habituation, Psychophysiologic | 1 | 2008 | 32 | 0.300 |
Why?
| Patient Acceptance of Health Care | 4 | 2023 | 337 | 0.300 |
Why?
| Time Factors | 4 | 2018 | 2909 | 0.270 |
Why?
| Adolescent | 5 | 2022 | 6459 | 0.260 |
Why?
| Cesarean Section | 2 | 2024 | 185 | 0.240 |
Why?
| Hemoglobinopathies | 1 | 2024 | 2 | 0.240 |
Why?
| Livedo Reticularis | 1 | 2024 | 6 | 0.240 |
Why?
| Skin Diseases, Vascular | 1 | 2024 | 9 | 0.240 |
Why?
| Visual Pathways | 1 | 2004 | 11 | 0.240 |
Why?
| Aged | 5 | 2024 | 9505 | 0.240 |
Why?
| Optical Devices | 1 | 2024 | 3 | 0.230 |
Why?
| Optical Phenomena | 1 | 2024 | 10 | 0.230 |
Why?
| Infant | 3 | 2023 | 3584 | 0.230 |
Why?
| Pressure | 1 | 2024 | 105 | 0.230 |
Why?
| Cyanosis | 1 | 2024 | 17 | 0.230 |
Why?
| Rest | 1 | 2024 | 60 | 0.230 |
Why?
| Equipment Design | 1 | 2025 | 290 | 0.230 |
Why?
| Middle Aged | 6 | 2024 | 12356 | 0.220 |
Why?
| Heart Conduction System | 1 | 2003 | 23 | 0.220 |
Why?
| Fee-for-Service Plans | 1 | 2023 | 19 | 0.210 |
Why?
| Morbidity | 1 | 2023 | 132 | 0.210 |
Why?
| Case-Control Studies | 3 | 2020 | 1145 | 0.210 |
Why?
| Embryonic and Fetal Development | 1 | 2002 | 20 | 0.210 |
Why?
| Autonomic Nervous System | 1 | 2023 | 57 | 0.210 |
Why?
| Cooperative Behavior | 2 | 2014 | 226 | 0.200 |
Why?
| Lactation | 1 | 2022 | 59 | 0.200 |
Why?
| Chronic Disease | 1 | 2024 | 568 | 0.200 |
Why?
| Health Care Costs | 1 | 2023 | 168 | 0.200 |
Why?
| Socioeconomic Factors | 3 | 2023 | 584 | 0.200 |
Why?
| Sensitivity and Specificity | 3 | 2011 | 871 | 0.200 |
Why?
| Anticoagulants | 1 | 2024 | 253 | 0.200 |
Why?
| Comorbidity | 1 | 2023 | 612 | 0.190 |
Why?
| Skin | 1 | 2024 | 416 | 0.190 |
Why?
| Biomedical Research | 2 | 2014 | 242 | 0.190 |
Why?
| Signal-To-Noise Ratio | 1 | 2021 | 20 | 0.180 |
Why?
| Fetal Movement | 2 | 2018 | 20 | 0.180 |
Why?
| Prevalence | 1 | 2023 | 960 | 0.180 |
Why?
| Referral and Consultation | 1 | 2022 | 284 | 0.180 |
Why?
| ROC Curve | 2 | 2018 | 236 | 0.180 |
Why?
| Auditory Perception | 1 | 2020 | 29 | 0.180 |
Why?
| Subtraction Technique | 1 | 2020 | 14 | 0.170 |
Why?
| Arrhythmias, Cardiac | 1 | 2021 | 91 | 0.170 |
Why?
| Predictive Value of Tests | 2 | 2018 | 921 | 0.170 |
Why?
| Mothers | 1 | 2022 | 256 | 0.170 |
Why?
| Hospitalization | 1 | 2023 | 665 | 0.160 |
Why?
| Personal Satisfaction | 1 | 2019 | 77 | 0.160 |
Why?
| Magnetic Fields | 1 | 2018 | 11 | 0.160 |
Why?
| Manometry | 1 | 2018 | 22 | 0.160 |
Why?
| Wakefulness | 2 | 2011 | 49 | 0.160 |
Why?
| Vagina | 1 | 2018 | 45 | 0.150 |
Why?
| Computer Simulation | 3 | 2015 | 281 | 0.150 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2021 | 553 | 0.150 |
Why?
| Ultrasonography, Prenatal | 2 | 2013 | 190 | 0.150 |
Why?
| Pulse | 1 | 2017 | 15 | 0.140 |
Why?
| Attitude to Computers | 1 | 2017 | 18 | 0.140 |
Why?
| Blood Pressure Monitoring, Ambulatory | 1 | 2017 | 35 | 0.140 |
Why?
| Optics and Photonics | 1 | 2017 | 11 | 0.140 |
Why?
| Remote Consultation | 1 | 2017 | 29 | 0.140 |
Why?
| Cerebral Palsy | 1 | 2016 | 39 | 0.130 |
Why?
| Transportation | 1 | 2016 | 31 | 0.130 |
Why?
| Radiography, Abdominal | 1 | 2015 | 27 | 0.130 |
Why?
| Manduca | 1 | 2015 | 2 | 0.130 |
Why?
| Metamorphosis, Biological | 1 | 2015 | 2 | 0.130 |
Why?
| Models, Organizational | 1 | 2015 | 57 | 0.130 |
Why?
| Body Size | 1 | 2015 | 27 | 0.120 |
Why?
| Sexual Behavior | 1 | 2016 | 115 | 0.120 |
Why?
| Body Weight | 1 | 2017 | 513 | 0.120 |
Why?
| Blood Pressure | 1 | 2017 | 527 | 0.120 |
Why?
| Oxygen | 1 | 2017 | 321 | 0.120 |
Why?
| Stress, Physiological | 1 | 2015 | 174 | 0.110 |
Why?
| Promethazine | 1 | 2014 | 11 | 0.110 |
Why?
| Social Networking | 1 | 2014 | 15 | 0.110 |
Why?
| Ondansetron | 1 | 2014 | 13 | 0.110 |
Why?
| Reaction Time | 2 | 2005 | 215 | 0.110 |
Why?
| Antiemetics | 1 | 2014 | 32 | 0.110 |
Why?
| Child Development | 2 | 2014 | 193 | 0.110 |
Why?
| Sleep Stages | 1 | 2013 | 42 | 0.110 |
Why?
| Vomiting | 1 | 2014 | 73 | 0.110 |
Why?
| Reference Values | 1 | 2013 | 309 | 0.110 |
Why?
| Social Support | 1 | 2014 | 263 | 0.100 |
Why?
| Software | 1 | 2014 | 273 | 0.100 |
Why?
| Smoking | 1 | 2016 | 506 | 0.100 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2014 | 185 | 0.100 |
Why?
| Child, Preschool | 1 | 2020 | 3896 | 0.100 |
Why?
| Child | 1 | 2022 | 6862 | 0.090 |
Why?
| Models, Neurological | 1 | 2010 | 57 | 0.080 |
Why?
| Biological Clocks | 1 | 2009 | 18 | 0.080 |
Why?
| Statistics as Topic | 1 | 2010 | 88 | 0.080 |
Why?
| Pattern Recognition, Automated | 1 | 2009 | 41 | 0.080 |
Why?
| Electrophysiology | 1 | 2009 | 80 | 0.080 |
Why?
| Cross-Sectional Studies | 2 | 2024 | 1580 | 0.080 |
Why?
| Patient Satisfaction | 2 | 2020 | 280 | 0.080 |
Why?
| Delta Rhythm | 1 | 2007 | 7 | 0.070 |
Why?
| Risk Factors | 1 | 2016 | 3644 | 0.070 |
Why?
| Placental Insufficiency | 1 | 2007 | 4 | 0.070 |
Why?
| Flecainide | 1 | 2006 | 5 | 0.070 |
Why?
| Anti-Arrhythmia Agents | 1 | 2006 | 81 | 0.070 |
Why?
| Fetal Diseases | 1 | 2006 | 61 | 0.070 |
Why?
| Tachycardia, Supraventricular | 1 | 2006 | 39 | 0.070 |
Why?
| Pitch Perception | 1 | 2005 | 10 | 0.060 |
Why?
| Spectrum Analysis | 1 | 2006 | 71 | 0.060 |
Why?
| Electrocardiography | 1 | 2006 | 259 | 0.060 |
Why?
| Labor Stage, First | 1 | 2004 | 9 | 0.060 |
Why?
| Maternal Age | 1 | 2004 | 43 | 0.060 |
Why?
| Insurance Coverage | 1 | 2024 | 110 | 0.050 |
Why?
| Mortality | 1 | 2023 | 97 | 0.050 |
Why?
| Hospitals, Private | 1 | 2022 | 3 | 0.050 |
Why?
| Health Surveys | 1 | 2022 | 235 | 0.050 |
Why?
| Triage | 1 | 2020 | 61 | 0.040 |
Why?
| Emergency Service, Hospital | 1 | 2023 | 482 | 0.040 |
Why?
| Longitudinal Studies | 2 | 2014 | 700 | 0.040 |
Why?
| Qualitative Research | 1 | 2020 | 337 | 0.040 |
Why?
| Health Personnel | 1 | 2020 | 250 | 0.040 |
Why?
| Telephone | 1 | 2017 | 70 | 0.030 |
Why?
| Aged, 80 and over | 1 | 2023 | 3158 | 0.030 |
Why?
| Larva | 1 | 2015 | 27 | 0.030 |
Why?
| Program Evaluation | 1 | 2017 | 347 | 0.030 |
Why?
| Food | 1 | 2015 | 68 | 0.030 |
Why?
| Age Distribution | 1 | 2015 | 169 | 0.030 |
Why?
| Temperature | 1 | 2015 | 165 | 0.030 |
Why?
| Schools, Medical | 1 | 2014 | 70 | 0.030 |
Why?
| Genetic Variation | 1 | 2015 | 215 | 0.030 |
Why?
| Practice Guidelines as Topic | 1 | 2017 | 459 | 0.030 |
Why?
| Rural Population | 1 | 2017 | 551 | 0.030 |
Why?
| Diseases in Twins | 1 | 2006 | 15 | 0.020 |
Why?
| Pregnancy, Multiple | 1 | 2006 | 23 | 0.020 |
Why?
| Twins | 1 | 2006 | 33 | 0.020 |
Why?
| Electromagnetic Fields | 1 | 2005 | 16 | 0.020 |
Why?
| Analysis of Variance | 1 | 2006 | 563 | 0.020 |
Why?
| Data Interpretation, Statistical | 1 | 2005 | 159 | 0.010 |
Why?
| Confidence Intervals | 1 | 2004 | 155 | 0.010 |
Why?
| Age Factors | 1 | 2004 | 1096 | 0.010 |
Why?
| Aging | 1 | 2005 | 674 | 0.010 |
Why?
| Animals | 1 | 2015 | 13141 | 0.010 |
Why?
|
|
Eswaran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|